EUVIMEDEUVIMED entdecken
Crossref

Dexamethasone-Integrated Mesenchymal Stem Cells for Systemic Lupus Erythematosus Treatment via Multiple Immunomodulatory Mechanisms

Wenjuan Ma iD, Junyi Che iD, Weiwei Chen, Dandan Wang, Huayong Zhang, Yuanjin Zhao iD

ACS Nano · 2024

DOI: 10.1021/acsnano.4c02420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Wenjuan Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing 210008, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Dexamethasone, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Jiangsu Provincial Key Research and Development Program, National Key Research and Development Program of China, Major International Joint Research Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsDexamethasoneLupus Erythematosus, SystemicAnimalsMiceLiposomesMesenchymal Stem Cell TransplantationCell ProliferationFemaleMice, Inbred MRL lprHumansCD4-Positive T-LymphocytesAnti-Inflammatory Agents

Stichwörter der Autor:innen

cellular reprogrammingdexamethasonedrug deliveryglucocorticoid receptormesenchymal stem cellsystemic lupus erythematosus

Substanzen

DexamethasoneLiposomesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing 210008, China.
  • Department of Pharmacy, The First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.
  • State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.

ORCID-Profile: Wenjuan Ma, Junyi Che, Yuanjin Zhao

Förderung

  • Jiangsu Provincial Key Research and Development Program
  • National Key Research and Development Program of China
  • Major International Joint Research Programme
  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Jiangsu Province
  • Natural Science Foundation of Fujian Province
  • National Natural Science Foundation of China
  • Jiangsu Province Health Department Foundation

Zitieren

APA

Ma, W., Che, J., Chen, W., Wang, D., Zhang, H., & Zhao, Y. (2024). Dexamethasone-Integrated Mesenchymal Stem Cells for Systemic Lupus Erythematosus Treatment via Multiple Immunomodulatory Mechanisms. ACS Nano. https://doi.org/10.1021/acsnano.4c02420

Vancouver

Ma W, Che J, Chen W, Wang D, Zhang H, Zhao Y. Dexamethasone-Integrated Mesenchymal Stem Cells for Systemic Lupus Erythematosus Treatment via Multiple Immunomodulatory Mechanisms. ACS Nano. 2024. doi:10.1021/acsnano.4c02420

BibTeX
@article{Ma2024,
  author = {Ma, Wenjuan and Che, Junyi and Chen, Weiwei and Wang, Dandan and Zhang, Huayong and Zhao, Yuanjin},
  title = {Dexamethasone-Integrated Mesenchymal Stem Cells for Systemic Lupus Erythematosus Treatment via Multiple Immunomodulatory Mechanisms},
  journal = {ACS Nano},
  year = {2024},
  doi = {10.1021/acsnano.4c02420}
}
Kostenlos starten →